HOLLY WUEST: Open Payments
NPI 1588932172 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 72 payments from 18 companies in 2025. Trend: 2023 $1,004 · 2024 $1,594 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $472 |
| GlaxoSmithKline, LLC. | 10 | $265 |
| Regeneron Healthcare Solutions, Inc. | 6 | $261 |
| GENZYME CORPORATION | 10 | $139 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| HARMONY BIOSCIENCES LLC | 5 | $110 |
| Grifols USA, LLC | 4 | $104 |
| Verona Pharma, Inc. | 3 | $67 |
| Baxter Healthcare | 2 | $61 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, FASENRA, LUMRYZ, TRELEGY ELLIPTA, WAKIX, Prolastin-C Liquid.
Industry payments across MI — which companies pay providers there.
